Numerous genetic mutations are linked to increased risk for breast cancer. Genetic testing can identify these mutations and guide patient management decisions. Over the past decade, multi-gene panel tests have gained traction in clinical settings. These evaluate up to 43 breast cancer-related genes, compared with limited BRCA 1 and BRCA2 (BRCA1/2) tests.
Lung cancer screening can detect tumors while they are still small and more likely to be successfully treated. Low-dose computed tomography (LDCT) is an effective lung cancer screening tool appropriate for high-risk patients. For specific patients, the American Society of Clinical Oncology, American Cancer Society and U.S. Preventive Services Task Force (USPSTF) all recommend annual LDCT to screen for lung cancer.
Mammography uses X-ray technology to produce images of breast tissue. These images can reveal tumors and other abnormalities, such as lumps and calcifications. As a screening exam, mammography is proven to save lives. Many health care professionals and organizations, including the American Cancer Society, agree that women should be screened annually beginning at age 40.
Inherited genetic mutations can increase a woman’s risk of developing breast cancer. For instance, a mutation in two of the better-understood genes linked to a substantial increased risk of breast cancer, the BRCA1 and BRCA2 genes, account for up to:
Much attention paid to multiparametric prostate MRI has focused on its ability to improve prostate cancer detection and diagnosis. However, prostate MRI has the potential to improve other aspects of prostate cancer care. Beyond guiding biopsy needles, prostate MRI can also aid prostate cancer staging, inform treatment planning and to monitor patients following treatment.
Nearly 850,000 men will be diagnosed with cancer in 2015, according to American Cancer Society estimates. National Men’s Health Week, which occurs every June around Father’s Day, was established to help raise awareness around men’s health issues.
Numerous factors impact the possibility that a woman will be confronted with a diagnosis of breast cancer during her life. However, there are steps every woman can take to reduce her risk and promote overall health. This year, for National Women’s Health Week, we would like to share some of the steps you can take lower your risk of breast cancer.
Researchers have identified multiple risk factors that increase a woman’s chances for developing breast cancer.
March is National Colon & Rectum Cancer Awareness Month. This post is the first installment of a two part series to promote colorectal cancer awareness.
This year at the San Antonio Breast Cancer Symposium (SABCS) there were two aspects of breast cancer that were clearly emphasized: use of ovarian suppression in premenopausal women with breast cancer and advances in genetic testing for hereditary cancer predisposition.
Results of the SOFT trial (further detailed by Dr. Wade Smith in this post), show a clear benefit to the addition of ovarian suppression in women under the age of 35. This benefit resembles that seen with the addition of Herceptin for HER2+ cancer, and now calls for a change in practice management.